Merck's Ebola shot delivers antibodies that could last 2 years or more, study finds - FiercePharma

FiercePharma
Merck's Ebola shot delivers antibodies that could last 2 years or more, study finds
FiercePharma
Previous studies have shown that Merck & Co.'s Ebola vaccine can act fast and can maintain an antibody response for at least one year. Now, a new study has doubled that estimate. The new study, published in Lancet Infectious Diseases, shows antibodies ...and more »